RESTYLANE EYELIGHT is the latest addition to the RESTYLANE product portfolio, expanding the world's most diverse filler portfolio. Due to the diverse gel characteristics, the RESTYLANE product portfolio allows us to provide personalized treatments that patients need.

RESTYLANE EYELIGHT is a gel designed for precise treatment of the periorbital area, thanks to NASHA technology, which provides targeted correction with high resistance to mechanical forces and low diffusion into surrounding tissue. The patient's overall facial appearance is improved, and the full treatment can last up to two years. The periorbital area is one of the first areas where signs of aging appear on the face.

Volume loss causes the periorbital area to sag, which can lead to lacrimal duct deformities (LDUs). This loss of volume creates shadows and accentuates dark circles. The main causes of LDUs are multifaceted. The three main factors are: Genetics: genetic anatomical differences are already evident in young patients; Aging, resulting in a decrease in the area's volume; and The combination of genetics, aging, and lifestyle factors creates a "tired" appearance.

A PRECISE treatment, indicated for the periorbital area with satisfactory results. RESTYLANE EYELIGHT offers targeted correction of the tear trough and significantly reduces dark shadows for a rested appearance.

RECOMMENDED by patients who have already been treated: 94.3% would repeat the treatment and recommend it to a friend.

The package contains a 0.5ml syringe

Expiration 12/2025